CADL
NASDAQ HealthcareCandel Therapeutics, Inc. - Common Stock
Biotechnology
Candel Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies for cancer patients. It develops CAN-2409, which is in Phase 2a clinical trials for the treatment of prostate cancer; and Phase 2a clinical trials for the treatment of non-small cell lung cancer (NSCLC). The company is also developing CAN-3110, which is in Phase Ib clinical trials for the treatment of recurrent high-grade glioma. In addition, it develops the enLIGHTEN Discovery Platform, a systematic, iterative herpes simplex virus based discovery platform leveraging human biology and advanced analytics to create new viral immunotherapy candidates for solid tumors. The company was formerly known as Advantagene, Inc. and changed its name to Candel Therapeutics, Inc. in November 2020. Candel Therapeutics, Inc. was incorporated in 2003 and is headquartered in Needham, Massachusetts.
๐ Market Data
| Price | $6.47 |
|---|---|
| Volume | 1,588,995 |
| Market Cap | 474.06M |
| Beta | -0.810 |
| RSI (14-Day) | 68.3 |
| 200-Day MA | $5.55 |
| 50-Day MA | $5.34 |
| 52-Week High | $7.66 |
| 52-Week Low | $4.34 |
| Forward P/E | -10.11 |
| Price / Book | 6.84 |
๐ฏ Investment Strategy Scores
CADL scores across each investment strategy. Higher is better for that strategy's goals.
๐ Strategy Interpretation
Best fit: ๐ Over-Hyped (79/100) โ this strategy Overbought stocks (potential short candidates).
Lowest fit among scored strategies: ๐ Institutional Whale (12/100). No single score is a buy or sell signal โ use multiple lenses together. Learn how to read these scores โ
๐ Learn More
Indicators on this page
Educational articles
Find CADL in your text
Paste any article, transcript, or post โ the tool will extract CADL and every other hidden ticker.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.